PT - JOURNAL ARTICLE AU - Colbert, Sarah M.C. AU - Lepow, Lauren AU - Fennessy, Brian AU - Iwata, Nakao AU - Ikeda, Masashi AU - Saito, Takeo AU - Terao, Chikashi AU - Preuss, Michael AU - Pathak, Jyotishman AU - Mann, J. John AU - Coon, Hilary AU - Mullins, Niamh TI - Distinguishing clinical and genetic risk factors for suicidal ideation and behavior in a diverse hospital population AID - 10.1101/2024.07.30.24311218 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.30.24311218 4099 - http://medrxiv.org/content/early/2024/08/02/2024.07.30.24311218.short 4100 - http://medrxiv.org/content/early/2024/08/02/2024.07.30.24311218.full AB - Suicidal ideation (SI) and behavior (SB) are major public health concerns, but risk factors for their development and progression are poorly understood. We used ICD codes and a natural language processing algorithm to identify individuals in a hospital biobank with SI-only, SB, and controls without either. We compared the profiles of SB and SI-only patients to controls, and each other, using phenome-wide association studies (PheWAS) and polygenic risk scores (PRS). PheWAS identified many risk factors for SB and SI-only, plus specific psychiatric disorders which may be involved in progression from SI-only to SB. PRS for suicide attempt were only associated with SB, and even after accounting for psychiatric disorder PRS. SI PRS were only associated with SI-only, although not after accounting for psychiatric disorder PRS. These findings advance understanding of distinct genetic and clinical risk factors for SB and SI-only, which will aid in early detection and intervention efforts.Competing Interest StatementDr. Mann receives royalties for commercial use of the C-SSRS from the Research Foundation for Mental Hygiene and from Columbia University for the Columbia Pathways App. The other authors have no conflicts of interest to declare.Funding StatementThis material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1842169 (PI Colbert), the National Institute of Mental Health R01MH123489 (PI Coon), and the Brain and Behavior Research Foundation NARSAD Young Investigator Award No: 29551 (PI Mullins). This work was supported in part through the computational and data resources and staff expertise provided by Scientific Computing and Data at the Icahn School of Medicine at Mount Sinai and supported by the Clinical and Translational Science Awards (CTSA) grant UL1TR004419 from the National Center for Advancing Translational Sciences. Research reported in this publication was also supported by the Office of Research Infrastructure of the National Institutes of Health under award number S10OD026880 and S10OD030463. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Work for the Japanese cohort was supported by Japan Agency for Medical Research and Development (AMED) grants JP24dk0307123, 22wm0425008, 21ek0109555, 21tm0424220, 21ck0106642, 23ek0410114 and 23tm0424225, Japan Society for the Promotion of Science (JSPS) KAKENHI grant JP22H03003, JP21H02854 and JP20H00462.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Relevant study activities for the current report were approved by the Icahn School of Medicine at Mount Sinai Institutional Review Board (Institutional Review Board 07 0529) and all study participants provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesResearchers can apply for BioMe data access through dbGaP. dbGaP study accession: phs001644.v1.p1) https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001644.v1.p1